$58 Million Settlement over a False Claims Act Allegations Against Novo Nordisk Inc Announced by Whistleblower Institute
The Whistleblower Institute announces that Novo Nordisk Inc reached a $58 million settlement in a whistleblower lawsuit over failing to Comply with FDA-Mandated Risk Program.
View full press release